BMR Genomics

What BMR Genomics does

BMR Genomics S.r.l. is an Italian DNA analysis service provider founded in 1997 and headquartered in Padua (Via Redipuglia 21A), operating as a private limited company with €110,000 share capital and 11-50 employees. The company delivers Sanger sequencing on ABI capillary sequencers and Next-Generation Sequencing on Illumina platforms (NovaSeq 6000, MiSeq i100 Plus with XLEAP-SBS chemistry installed April 2025), supported by Beckman automation, Illumina BeadChip and MethylationEPIC arrays, Promega PowerPlex Fusion STR profiling, and LGC KASP genotyping. Service areas include molecular microbiology (16S/ITS), RNA-seq, target enrichment/exome, whole-genome sequencing of small genomes, DNA methylation at over 930,000 CpG sites, and pharmacogenomics reporting aligned with DPWG/CPIC and EMQN VEQ standards. Bioinformatics is delivered through proprietary Qiime2-based taxonomic pipelines, PLINK-based GWAS, and three-tier methylation analysis, complemented by recurring paid training courses (480-599 EUR) in basic bioinformatics, 16S-NGS, RNA-seq, and variant calling. Distribution is via a web-based booking and results portal with dedicated per-service customer care and an SDA courier sample-logistics partnership.

The company sells primarily on a per-sample or per-project transaction basis to five horizontal segments: universities and research centers, hospitals and medical foundations, biotech/pharma and food industry enterprises, professionals (lawyers, doctors, veterinarians), and private individuals served through sub-brands SalusNet and Test DNA Paternità. Customer relationships are reinforced by prepaid service packages and recurring training. BMR is ISO 9001:2015 certified (DNV), is the official Promega cell authentication provider in Italy, achieved EMQN VEQ compliance for pharmacogenomics in 2025, and is pursuing ISO 15189 medical genetics accreditation with Accredia. Revenue is augmented by substantial EU and regional non-dilutive funding through POR FESR, FSC, and PNRR Ecosistemi dell'Innovazione programs (RIxAA, AMELIA, MiMaMeNu, MIIT, SEBiomeD, SOSIAQ), with active consortium participation in the RIBES-Nest Smart Health regional innovation network alongside Università di Padova, CNR, Fidia Farmaceutici, Micromed, and others. Ownership is concentrated among the founding team: Prof. Giorgio Valle (Board President), Paolo Baratto, and Eleonora Sattin.

Name

BMR Genomics

Legal name

BMR Genomics S.r.l.

Website

https://bmr-genomics.it

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

BMR Genomics is an Italian DNA analysis service provider (founded 1997, Padua) offering Sanger and Illumina NGS sequencing, SNP genotyping, methylation, pharmacogenomics, and bioinformatics training to universities, hospitals, biotech firms, and private individuals across Europe.

Ownership category

akta.pro rank

Product category

Genomics Services

NAICS

Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Epigenomics & Chromatin Profiling Services (HLAGANAF)

Keywords

• DNA sequencing services
• Next generation sequencing
• SNP genotyping
• Bioinformatics analysis
• Pharmacogenomics testing

Headquarters

HQ city

Padua

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. DNA Sequencing Services (Sanger and NGS): Core revenue from Sanger sequencing (Solo corsa, Essential, Premium tiers) and Next Generation Sequencing services (16S-NGS, ITS-NGS, RNA-seq, WGS, Target Enrichment). Customers include universities, hospitals, research centers, companies, and private individuals. Revenue is transaction-based per sample or per project.
2. SNP Genotyping and Pharmacogenomics: Genotyping services using Illumina BeadChip (GSA, GDA, custom ChrySalus arrays), KASP assay, and DNA methylation analysis. Includes pharmacogenomics reporting against DPWG and CPIC guidelines.
3. Custom Projects: Custom NGS and Sanger projects tailored to specific research needs, including custom primer development, non-standard amplicon sequencing, and bespoke bioinformatics analysis.
4. Bioinformatics Training Courses: Revenue from bioinformatics training courses (basic, 16S-NGS, RNA-seq, Variant Calling) priced at 480-599 EUR per person. Also offers personalized training programs and bioinformatics consulting packages.
5. Consumables and Reagents (EasyShop, Custom Primer): E-commerce resale of laboratory consumables, reagents, and custom primers for molecular biology laboratories.
6. Prepaid Service Packages: Prepaid credit packages allowing customers to prepay for sequencing services at discounted rates, providing recurring revenue visibility and customer lock-in.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

BMR Genomics provides end-to-end DNA analysis services including Sanger sequencing (ABI capillary sequencers), Next Generation Sequencing on Illumina platforms (NovaSeq 6000, MiSeq i100 Plus), SNP genotyping, DNA methylation analysis, pharmacogenomics, and bioinformatics interpretation. Services are delivered from sample receipt through automated laboratory processing to data delivery, supported by an integrated team of biologists and computer scientists managing proprietary bioinformatics pipelines.

Product overview

BMR Genomics is a DNA analysis service company founded in 1997, operating as a unified portfolio of interconnected laboratory and bioinformatics services. The core offering is built around two principal sequencing platforms: Sanger Sequencing (capillary electrophoresis using ABI instruments) and Next Generation Sequencing (Illumina platforms including MiSeq i100 Plus and NovaSeq 6000). These platforms are supported by specialized service areas including Molecular Microbiology (16S rRNA and ITS sequencing for bacterial and fungal identification), SNP Genotyping (Illumina BeadChip, KASP, and methylation analysis), Pharmacogenomics, and GeneScan fragment analysis. Bioinformatics Analysis and Bioinformatics Training Courses extend the portfolio by providing computational data interpretation and educational services. Complementary offerings include Custom Projects (tailored research collaborations), Custom Primer and EasyShop ( consumables/shop services), and the sub-branded SalusNet and Test DNA Paternita platforms for consumer genetic testing. The service portfolio is ISO 9001:2015 certified and targets universities, research centers, hospitals, healthcare professionals, and private individuals.

Differentiator

Problem solved

Functional benefit

Brands

• SalusNet: A related brand/website operated by BMR Genomics for health-related DNA services
• Test DNA Paternità

Products and services

• Sanger Sequencing Capillary electrophoresis DNA sequencing using ABI sequencers, offered in three tiers: Solo Corsa (electrophoresis only), Essential (reaction + electrophoresis with electronic QC), and Premium (full service with manual QC, technical support, and repeat capability). Targets researchers, universities, and biotech customers.
• Next Generation Sequencing (NGS) High-throughput sequencing services including amplicon sequencing (16S-NGS, ITS-NGS), RNA-Seq, Target Enrichment/exome sequencing, Whole Genome Sequencing of small microbial genomes, and Custom NGS projects. Runs on Illumina NovaSeq 6000 and MiSeq i100 Plus platforms.
• Molecular Microbiology (16S rRNA and ITS sequencing) Identification and characterization of bacterial and fungal communities in complex matrices (feces, soil, food, serum, milk) using Sanger (16S rRNA, ITS) and NGS (16S-NGS, ITS-NGS) approaches. Includes bacterial identification via 16S rRNA and fungal identification via ITS region.
• STR Human Typing and Cell Line Authentication STR profiling service using the Promega PowerPlex Fusion kit covering 23 STR loci plus Amelogenin for gender determination. Includes Cell Profile authentication for human cell lines (from 94 EUR per sample) and paternity/kinship analysis under the Identification and Parentela sub-service.
• SNP Genotyping Advanced SNP genotyping services using Illumina BeadChip (Global Screening Array ~700K variants, Global Diversity Array ~1.8M variants), KASP-assay for targeted SNPs, and pharmacogenomics panels (GDA-PGx, DRAGEN Array). Targets researchers and clinical customers.
• DNA Methylation Analysis DNA methylation analysis using Illumina MethylationEPIC beadchip interrogating over 930,000 genomic sites including CpG islands, enhancers, promoters, and open chromatin regions. Three-tier delivery: QC and data preparation, batch effect correction and normalization, and differential methylation analysis (DMP/DMR) with biological interpretation.
• Pharmacogenomics Pharmacogenomics analysis using Infinium Global Diversity Array with Enhanced PGx (Illumina GDA-PGx) and DRAGEN Array Illumina, supporting clinical decision-making in precision medicine. Results interpreted using DPWG and CPIC databases with EMQN VEQ compliance.
• Bioinformatics Analysis and Training Courses Bioinformatics services including taxonomic analysis via Qiime2 pipelines (ASV detection with DADA2, Greengenes2/Silva138/UNITE databases), GWAS using linear mixed models, RNA-seq differential expression analysis, PLINK-based quality control, and custom pipeline development. Paired with training courses (basic bioinformatics, 16S-NGS, RNA-seq, variant calling) at 480-599 EUR per person.
• Custom Projects Custom research projects tailored to client requirements, including whole vector insert sequencing (plasmids, BACs, PACs), microsatellite genotyping, exon sequencing, single SNP validation, custom gene panel analysis, small genome sequencing, and bespoke bioinformatics analyses.
• GeneScan (Fragment Analysis) DNA fragment electrophoresis service using Applied Biosystems automated sequencers for microsatellite and fragment genotyping analysis. Supports various fluorophore markers and size standards for STR analysis and fragment sizing applications.
• Bioanalyzer Service Agilent Bioanalyzer 2100 service for qualitative and semi-quantitative analysis of DNA and RNA using capillary electrophoresis chip technology. Offers the DNA HS kit (50-7000 bp) for fragment size verification and library quality control.
• SalusNet Consumer Health DNA Testing Consumer health DNA testing platform (salusnet.eu) operated by BMR Genomics, providing personal genetic testing services for individual customers.
• Test DNA Paternità (Paternity Testing) Direct-to-consumer DNA paternity testing service (testdnapaternita.com) operated by BMR Genomics, providing confidential paternity testing for private individuals.

Quantifiable outcome

• Turnaround time of 2-3 working days for urgent bacterial 16S Sanger sequencing (BACT16S-500 FAST)
• +5 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Partnerships

27 partnerships are on record, tiered core and minor.

• RIBES-Nest per l'Ecosistema Salute e l'Alimentazione SmartcoreStrategic or Co-development Partner · 2 October 2024RIBES-Nest is the Smart Health regional innovation network (RIR) of which BMR Genomics is an active member. BMR participates in multiple collaborative R&D projects through this network, including RIxAA (Active Ageing research) and SEBiomeD (biomedical devices export promotion). BMR is also a project partner in the RIxAA initiative with 15+ consortium members including universities and companies.
• Clonit srlminorStrategic or Co-development Partner · 2 October 2024Clonit srl is a partner in the MIIT project (Monitoraggio Innovativo Idrosfera del Triveneto) alongside BMR Genomics, developing molecular NGS methods for identifying antibiotic resistance genes in aquatic environments under the PNRR One Health framework.
• Università degli Studi di PadovacoreStrategic or Co-development Partner · 2 October 2024University of Padova is a key research partner, collaborating in RIxAA (with Department of Biomedicina Comparata e Alimentazione) and other projects. BMR Genomics has a board member (Eleonora Sattin) who holds a PhD from the university.
• Università degli Studi di VeronaminorStrategic or Co-development Partner · 2 October 2024University of Verona participates as a research partner in the RIxAA Active Ageing project coordinated by RIBES-Nest.
• Università Cà Foscari di VeneziaminorStrategic or Co-development Partner · 2 October 2024Ca' Foscari University of Venice participates as a research partner in the RIxAA Active Ageing project coordinated by RIBES-Nest.
• Consiglio Nazionale delle Ricerche (IN)minorStrategic or Co-development Partner · 2 October 2024CNR (National Research Council of Italy) participates as a research partner in the RIxAA Active Ageing project coordinated by RIBES-Nest.
• Fidia FarmaceuticiminorStrategic or Co-development Partner · 2 October 2024Fidia Farmaceutici is a pharmaceutical company partner in the RIxAA project, contributing to research on bioactive compounds and active ageing.
• Micromed SpAminorStrategic or Co-development Partner · 2 October 2024Micromed SpA is a MedTech company partner in the RIxAA project and SEBiomeD export promotion project within the RIBES-Nest network.
• Telea Electronic EngineeringminorStrategic or Co-development Partner · 2 October 2024Telea Electronic Engineering is a partner in the RIxAA project and SEBiomeD project within the RIBES-Nest network, contributing technology expertise.
• DWS ProteinsminorStrategic or Co-development Partner · 2 October 2024DWS Proteins is a partner in the RIxAA project contributing protein biotechnology expertise for active ageing research.
• Fresenius Kabi IpsumminorStrategic or Co-development Partner · 2 October 2024Fresenius Kabi Ipsum is a pharmaceutical/healthcare company partner in the RIxAA project within the RIBES-Nest ecosystem.
• MicrobionminorStrategic or Co-development Partner · 2 October 2024Microbion is a biotech company partner in the RIxAA project within the RIBES-Nest Smart Health network.
• OxilabminorStrategic or Co-development Partner · 2 October 2024Oxilab is a research/industry partner in the RIxAA project within the RIBES-Nest network.
• + WattminorStrategic or Co-development Partner · 2 October 2024+ Watt is a partner in the RIxAA project within the RIBES-Nest ecosystem.
• Illumina Inc.coreTechnology or Integration · 2 October 2024BMR Genomics uses Illumina sequencing platforms (MiSeq, NovaSeq 6000, MiSeq i100 Plus) and array technologies (Infinium BeadChip, MethylationEPIC) as core infrastructure for its DNA analysis services. Illumina is a key technology provider for the company's laboratory operations.
• Regione del VenetocoreOthers · 2 October 2024Regione del Veneto is the primary public funding body for multiple BMR Genomics R&D projects including POR FESR 2014-2020, POR FESR 2021-2027, and FSC 2021-2027, providing grants and financial support totaling hundreds of thousands of euros.
• Distretto Ittico di Rovigo e ChioggiaminorStrategic or Co-development Partner · 19 July 2017SOSIAQ project (POR FESR 2014-2020) brought together the Fish District of Rovigo and Chioggia with BMR Genomics to innovate the shellfish supply chain using metagenomics for quality, safety, and sustainability.
• Istituto Zooprofilattico Sperimentale delle VenezieminorStrategic or Co-development Partner · 19 July 2017Research institute partner in the SOSIAQ project (POR FESR 2014-2020), collaborating on metagenomic analysis of the shellfish supply chain.
• Blupesca SrlminorStrategic or Co-development Partner · 19 July 2017Shellfish processing company partner in the SOSIAQ project (POR FESR 2014-2020 Action 1.1.4), collaborating with BMR Genomics on metagenomics for food quality.
• C.L.A.M. Soc.Coop.minorStrategic or Co-development Partner · 19 July 2017Shellfish fishing cooperative partner in the SOSIAQ project for food safety innovation.
• C.R.A.M.E. ChioggiaminorStrategic or Co-development Partner · 19 July 2017Shellfish processing company partner in the SOSIAQ project.
• Consorzio Cooperative Pescatori del Polesine Organizzazione di Produttori Soc. Coop.minorStrategic or Co-development Partner · 19 July 2017Fish producers cooperative consortium partner in the SOSIAQ shellfish innovation project.
• Finpesca SrlminorStrategic or Co-development Partner · 19 July 2017Seafood processing company partner in the SOSIAQ shellfish supply chain innovation project.
• EXPERTEAMminorStrategic or Co-development Partner · 19 July 2017Technology company partner in the SOSIAQ shellfish innovation project, providing technical expertise.
• Promega CorporationcoreTechnology or IntegrationBMR Genomics is an official Promega provider in Italy for the Cell Authentication service (PowerPlex Fusion System for human cell line STR profiling). Uses Promega kits for STR analysis and genotyping.
• SDA Express CourierminorChannel Partner/ Reseller/ DistributorSDA express courier partnership for sample logistics. BMR offers customers the option to ship samples via SDA at 10 EUR + VAT, with pickup from customer's address and delivery within 24-36 hours.
• Veneto InnovazioneminorImplementation/ SI/ Consulting PartnerVeneto Innovazione provided expert consulting during the PR FESR 2021-2027 Azione 1.4.1 project 'Checkup dell'informazione' to support BMR Genomics' innovation roadmap and ISO 15189 accreditation path.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Microsynth: Microsynth is a Swiss commercial DNA sequencing services laboratory offering Sanger, NGS (amplicon, WGS, RNA-seq), and bioinformatics to European academic and industrial customers with a similar fee-for-service model to BMR Genomics.
• Macrogen: Macrogen is a global sequencing services laboratory that markets Sanger, NGS, and bioinformatics analysis to research institutions worldwide, overlapping BMR's core Sanger/NGS and bioinformatics service portfolio and its university/hospital customer base.
• Eurofins Genomics: Eurofins Genomics is Europe's largest commercial DNA sequencing and genotyping services provider, offering Sanger, NGS, Sanger, and bioinformatics to academic and clinical customers across all of Europe, directly competing with BMR's core sequencing and SNP genotyping catalog.
• Source BioScience: Source BioScience is a UK-based genomics and laboratory services company offering Sanger sequencing, NGS, and bioinformatics to academic and clinical customers, comparable to BMR as a European mid-sized sequencing services specialist.
• Personal Genomics (Italy): Personal Genomics is an Italian DNA sequencing and diagnostics services provider based in Verona, operating in the same domestic market as BMR with comparable Sanger/NGS service offerings to universities, hospitals, and private customers.
• LGC Biosearch Technologies: LGC Biosearch Technologies provides genomics services (KASP genotyping, Sanger, NGS) to research customers and supplies the KASP reagents BMR uses, making them both a tooling partner and a direct commercial competitor in targeted SNP genotyping and genomics services.

Broad incumbents

• QIAGEN: QIAGEN is a global molecular biology and bioinformatics company that offers sample-prep, sequencing-related services, and clinical interpretation solutions, operating adjacent to BMR's lab services with a much broader life-sciences product portfolio.
• Genewiz (Azenta Life Sciences): Genewiz, now part of Azenta Life Sciences, is a global genomics services provider with Sanger, NGS, gene synthesis, and bioinformatics offerings, competing with BMR's sequencing services while operating at much larger scale across the broader life sciences value chain.
• Thermo Fisher Scientific (Sequencing Services): Thermo Fisher offers genomic services through its Life Sciences and Applied Biosystems brands alongside its broader instruments and reagents portfolio, covering Sanger, NGS, and bioinformatics offerings that overlap with BMR Genomics' core service catalog.

Others

• Illumina: Illumina is BMR's primary sequencing platform provider (NovaSeq 6000, MiSeq i100 Plus, BeadChips) rather than a competitor, but its new CLIA-certified service offerings and Axiom/Mendel collaborations partially overlap BMR's genomic analysis services, making it an ecosystem enabler and partial indirect competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/bmrgenomics
• LinkedInlinkedin.com/company/bmr-genomics

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BMR Genomics